Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cellular mechanisms implicated in anti-erythrocyte alloimmunization].

H Ansart-Pirenne1, P Rouger, F Noizat-Pirenne

  • 1Centre national de référence pour les groupes sanguins, Institut national de la transfusion sanguine, Inserm, U665, Paris, France. hansart@ints.fr

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|May 17, 2005
PubMed
Summary

Alloimmunization to blood group antigens (BGA) complicates transfusions. Understanding helper T cell responses to BGA peptides is key to developing new therapies for preventing antibody production.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel allele HLA-C*07:445 identified in a French hematopoietic stem cell donor.

HLA·2016
Same author

Transfusion service management of sickle-cell disease patients.

Vox sanguinis·2015
Same author

The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease.

Vox sanguinis·2014
Same author

[Transfusion and sickle cell disease: axes of transfusion safety optimization].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2014
Same author

International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012).

Vox sanguinis·2013
Same author

[The actual place of molecular analysis for donors and recipients in red blood cell immuno-hematology].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2013

Area of Science:

  • Immunology
  • Transfusion Medicine
  • Cellular Mechanisms

Background:

  • Blood transfusions are critical, but alloimmunization to blood group antigens (BGA) poses challenges.
  • Antibody production in BGA alloimmunization is T cell-dependent, yet T cell responses remain poorly understood.
  • This review focuses on cellular mechanisms driving antibody production in BGA alloimmunization.

Purpose of the Study:

  • To review recent advancements in understanding helper T cell responses in BGA alloimmunization.
  • To analyze immunodominant peptides, cytokine profiles, and HLA class II associations in BGA responses.
  • To explore potential therapeutic strategies based on identified T cell mechanisms.

Main Methods:

  • Analysis of immunodominant peptides from RhD and Jk(a) BGAs.

Related Experiment Videos

  • Characterization of induced cytokine patterns.
  • Investigation of implicated HLA class II molecules in peptide presentation.
  • Examination of a tolerogenic approach for RhD immunodominant peptides.

    • Main Results:

    • Definition of immunodominant peptides for RhD and Jk(a) BGAs.
    • Identification of specific cytokine patterns associated with these responses.
    • Elucidation of HLA class II molecules involved in presenting BGA peptides.
    • Experimental exploration of a tolerogenic pathway for RhD peptides.

    Conclusions:

    • Understanding BGA-specific T cell responses, including key peptides and HLA associations, is crucial.
    • This knowledge can guide the development of novel immunotherapies.
    • Targeted strategies like peptide antigen tolerogens or ex-vivo regulatory T cell induction show promise for controlling alloimmunization.